🇺🇸 FDA
Patent

US 10265439

Injectable cell-laden biohybrid hydrogels for cardiac regeneration and related applications

granted A61KA61K38/1866A61K47/32

Quick answer

US patent 10265439 (Injectable cell-laden biohybrid hydrogels for cardiac regeneration and related applications) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/1866, A61K47/32, A61K9/0024